ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,456, issued on Aug. 19, was assigned to Prilenia Neurotherapeutics Ltd. (Yakum, Israel).
"Pridopidine for treating Huntington's disease" was invented by Merav Bassan (Netanya, Israel), Esther Lukasiewicz Hagai (Tel Aviv, Israel), Eli Eyal (Petah-Tikva, Israel) and Anna Kristina Sveinsdotter Teige Wickenberg (Lund, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating a human patient afflicted with Huntington's disease, comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine, its analog or a pharmaceutically acceptable salt thereof."
The patent was filed on June 20, 2021, u...